Skip to main content
. 2024 Dec 28;43(1):51. doi: 10.1007/s00345-024-05388-1

Fig. 1.

Fig. 1

Kaplan Meier curves depicting time to metastatic castration resistant prostate cancer (CRPC, A) and overall survival (B) according treatment for high volume metastatic hormone-sensitive prostate cancer (mHSPC) stratified according to docetaxel vs. androgen receptor pathway inhibitor (ARPI)